Stepan’s FY25 results showed solid execution despite oleochemical inflation and market normalization. Net sales rose 7% y/y on better pricing/mix and volume, while adjusted EBITDA increased 11.7%, though adjusted EPS fell on a higher tax rate and after adjusting for the impact from one time asset sales. The Company continues footprint optimization under Project Catalyst, with management expecting ~$100M in pre-tax savings over the next two years, ~60% of which is expected in FY26. Management expects cost and tariff pressure to linger through 1H26, with improvement in 2H26 as costs ease, Pasadena reaches ~70-80% utilization, and Project Catalyst savings take effect. SCL also reported a net leverage ratio of 2.5x.